Translate Bio, Inc. is an early-clinical-stage biotechnology company developing mRNA therapeutics and vaccines targeting protein or gene dysfunction and infectious diseases respectively. Translate Bio ...
Daniel Shores, Andrew Storaska Ph.D. Translate Bio, Inc. (NASDAQ: TBIO) is headquartered in Lexington, MA, and as of April 2021, has a market capitalization of over $1.3 billion. According to its ...
Translate Bio CEO Ronald C. Renaud Jr. discusses his company, its mRNA platform, and its partnership with Sanofi in COVID-19 and other diseases as a guest in September 2020 on “GEN Live,” GEN’s ...
Over the past few years, Sanofi has increasingly upped its bet that vaccines and therapies based on messenger RNA (mRNA) technology could transform the drug industry. Now, the firm is going all in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results